Compounds > agreal
Page last updated: 2024-08-23

agreal and Parkinson Disease, Secondary

agreal has been researched along with Parkinson Disease, Secondary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franchignoni, FP; Tesio, L1
Sa, DS; Teive, HA1

Other Studies

2 other study(ies) available for agreal and Parkinson Disease, Secondary

ArticleYear
[Parkinson syndrome induced by veralipride].
    Minerva ginecologica, 1995, Volume: 47, Issue:6

    Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease, Secondary; Sulpiride

1995
Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
    Arquivos de neuro-psiquiatria, 2001, Volume: 59, Issue:1

    Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Sulpiride

2001